These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

344 related articles for article (PubMed ID: 25404717)

  • 1. Medication adherence among pediatric patients with sickle cell disease: a systematic review.
    Walsh KE; Cutrona SL; Kavanagh PL; Crosby LE; Malone C; Lobner K; Bundy DG
    Pediatrics; 2014 Dec; 134(6):1175-83. PubMed ID: 25404717
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Barriers to hydroxyurea adherence and health-related quality of life in adolescents and young adults with sickle cell disease.
    Badawy SM; Thompson AA; Penedo FJ; Lai JS; Rychlik K; Liem RI
    Eur J Haematol; 2017 Jun; 98(6):608-614. PubMed ID: 28306171
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systematic and Meta-Analytic Review: Medication Adherence Among Pediatric Patients With Sickle Cell Disease.
    Loiselle K; Lee JL; Szulczewski L; Drake S; Crosby LE; Pai AL
    J Pediatr Psychol; 2016 May; 41(4):406-18. PubMed ID: 26384715
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management of sickle cell disease: summary of the 2014 evidence-based report by expert panel members.
    Yawn BP; Buchanan GR; Afenyi-Annan AN; Ballas SK; Hassell KL; James AH; Jordan L; Lanzkron SM; Lottenberg R; Savage WJ; Tanabe PJ; Ware RE; Murad MH; Goldsmith JC; Ortiz E; Fulwood R; Horton A; John-Sowah J
    JAMA; 2014 Sep; 312(10):1033-48. PubMed ID: 25203083
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Multidimensional Electronic Hydroxyurea Adherence Intervention for Children With Sickle Cell Disease: Single-Arm Before-After Study.
    Creary S; Chisolm D; Stanek J; Hankins J; O'Brien SH
    JMIR Mhealth Uhealth; 2019 Aug; 7(8):e13452. PubMed ID: 31397291
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adherence to hydroxyurea, health-related quality of life domains, and patients' perceptions of sickle cell disease and hydroxyurea: a cross-sectional study in adolescents and young adults.
    Badawy SM; Thompson AA; Lai JS; Penedo FJ; Rychlik K; Liem RI
    Health Qual Life Outcomes; 2017 Jul; 15(1):136. PubMed ID: 28679417
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Allocation of Treatment Responsibility and Adherence to Hydroxyurea Among Adolescents With Sickle Cell Disease.
    Creary SE; Modi AC; Stanek JR; Chisolm DJ; O'Brien SH; Nwankwo C; Crosby LE
    J Pediatr Psychol; 2019 Nov; 44(10):1196-1204. PubMed ID: 31403687
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adherence to hydroxyurea medication by children with sickle cell disease (SCD) using an electronic device: a feasibility study.
    Inoue S; Kodjebacheva G; Scherrer T; Rice G; Grigorian M; Blankenship J; Onwuzurike N
    Int J Hematol; 2016 Aug; 104(2):200-7. PubMed ID: 27225236
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hydroxyurea adherence and associated outcomes among Medicaid enrollees with sickle cell disease.
    Candrilli SD; O'Brien SH; Ware RE; Nahata MC; Seiber EE; Balkrishnan R
    Am J Hematol; 2011 Mar; 86(3):273-7. PubMed ID: 21328441
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intentional and unintentional nonadherence to hydroxyurea among people with sickle cell disease: a qualitative study.
    Hodges JR; Phillips SM; Norell S; Nwosu C; Khan H; Luo L; Badawy SM; King A; Tanabe P; Treadwell M; Rojas Smith L; Calhoun C; Hankins JS; Porter J
    Blood Adv; 2020 Sep; 4(18):4463-4473. PubMed ID: 32941646
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A pilot study of electronic directly observed therapy to improve hydroxyurea adherence in pediatric patients with sickle-cell disease.
    Creary SE; Gladwin MT; Byrne M; Hildesheim M; Krishnamurti L
    Pediatr Blood Cancer; 2014 Jun; 61(6):1068-73. PubMed ID: 24436121
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Health-Related Quality of Life and Adherence to Hydroxyurea and Other Disease-Modifying Therapies among Individuals with Sickle Cell Disease: A Systematic Review.
    Yang M; Elmuti L; Badawy SM
    Biomed Res Int; 2022; 2022():2122056. PubMed ID: 35898672
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adherence to iron chelation therapy and associated healthcare resource utilization and costs in Medicaid patients with sickle cell disease and thalassemia.
    Vekeman F; Sasane M; Cheng WY; Ramanakumar AV; Fortier J; Qiu Y; Duh MS; Paley C; Adams-Graves P
    J Med Econ; 2016; 19(3):292-303. PubMed ID: 26618853
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Systematic Review of Medication Adherence Interventions in Pediatric Sickle Cell Disease.
    Shih S; Cohen LL
    J Pediatr Psychol; 2020 Jul; 45(6):593-606. PubMed ID: 32417887
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Beliefs about hydroxyurea in youth with sickle cell disease.
    Badawy SM; Thompson AA; Liem RI
    Hematol Oncol Stem Cell Ther; 2018 Sep; 11(3):142-148. PubMed ID: 29397333
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of the InCharge Health Mobile App to Improve Adherence to Hydroxyurea in Patients With Sickle Cell Disease: User-Centered Design Approach.
    Alberts NM; Badawy SM; Hodges J; Estepp JH; Nwosu C; Khan H; Smeltzer MP; Homayouni R; Norell S; Klesges L; Porter JS; Hankins JS
    JMIR Mhealth Uhealth; 2020 May; 8(5):e14884. PubMed ID: 32383683
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Technology Access and Smartphone App Preferences for Medication Adherence in Adolescents and Young Adults With Sickle Cell Disease.
    Badawy SM; Thompson AA; Liem RI
    Pediatr Blood Cancer; 2016 May; 63(5):848-52. PubMed ID: 26844685
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Health-related quality of life and adherence to hydroxyurea in adolescents and young adults with sickle cell disease.
    Badawy SM; Thompson AA; Lai JS; Penedo FJ; Rychlik K; Liem RI
    Pediatr Blood Cancer; 2017 Jun; 64(6):. PubMed ID: 27896936
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of daily medication adherence among children with sickle cell disease: a 1-year retrospective cohort analysis.
    Patel NG; Lindsey T; Strunk RC; DeBaun MR
    Pediatr Blood Cancer; 2010 Sep; 55(3):554-6. PubMed ID: 20658630
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adherence to hydroxyurea, health-related quality of life domains and attitudes towards a smartphone app among Irish adolescents and young adults with sickle cell disease.
    Fogarty H; Gaul A; Syed S; Aleksejenko N; Geoghegan R; Conroy H; Crampton E; Ngwenya N; Tuohy E; McMahon C
    Ir J Med Sci; 2022 Apr; 191(2):809-816. PubMed ID: 33745105
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.